Sinopharm Group
2C63 Shundicheng Building
Shuangtaizi District
Panjin City
Liaoning
124000
China
Tel: 86-427-3112783
Fax: 86-427-3582242
Website: http://www.sinopharmgroup.com/
37 articles about Sinopharm Group
-
Everest will pay Providence $50 million in cash upfront for access to its COVID-19 vaccine and other mRNA vaccine candidates targeting specific variants in earlier stages of development.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
-
The COVID-19 vaccine under development by China’s Sinopharm is showing efficacy of 86%, health authorities from the United Arab Emirates reported this morning.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 3, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 16, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
-
The cash will support the company’s 510(k) premarket notification submission to the FDA for its next-generation miniaturized robotically assisted surgical device.
-
Sinopharm Group Affiliate Pays $6.5 Million Milestone To Oramed
6/23/2016
-
AEterna Zentaris Announces IND Submission By Sinopharm A-Think
6/15/2016
-
Frontline BioVentures To Form Strategic Partnership With Sinopharm Group (“Sinopharm”)
12/4/2015
-
Sinopharm Group To Rake In $716 Million From Share Placement
11/24/2014
-
Provectus Biopharmaceuticals Inc. Signs Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry, And Sinopharm A-THINK Pharmaceutical Co., Ltd.
8/18/2014
-
Mitsubishi Corporation And Sinopharm Group Establish Medical Supplies Joint Venture In Shanghai
11/14/2013
-
Sinopharm Group and China NT Form $33 Million Acquisition Company
9/12/2013
-
Sinopharm Group to Build China's Largest Biotech R&D Center in Wuhan East Lake
8/6/2013
-
China NT Pharma and Sinopharm Group to Set Up Drug Distribution JV
4/2/2013
-
Week in Review: Sinopharm Group Building M&A War Chest
4/1/2013
-
Sinopharm Group Sells $515 Million of New Shares
4/1/2013
-
Week in Review: Sinopharm Group Pays $252 Million for Majority Stake in Winteam Pharma
3/5/2013
-
Sinopharm Group Buys 57% of Winteam Pharma for $252 Million
3/4/2013